$150K — $200K *
Agios is a biopharmaceutical company committed to applying our scientific leadership in cellular metabolism to transform the lives of patients with cancer and rare genetic diseases. We are growing rapidly with an active research and discovery pipeline across both therapeutic areas. Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development.
Agios is seeking a Senior Hematology Sales Consultant to join its team to sell IDHIFA® (enasidenib), an approved IDH2m inhibitor, and Tibsovo® (ivosidenib), a recently approved IDH1m inhibitor, both indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (R/R AML) having tested positive for the respective mutation. The Agios Senior Hematology Sales Consultant will also be responsible for the sales and marketing of Tibsovo® within the frontline AML setting.
Agios has a robust pipeline including multiple first-in-class investigational therapies. It has 3 molecules in clinical trials and multiple preclinical programs spanning its 3 research areas - cancer metabolism, rare genetic metabolic disorders, and metabolic immuno-oncology.
Agios is seeking top tier candidates to join its team as it strives to achieve its vision of developing innovative medications to transform the lives of patients.
We are looking for Senior Hematology Sales Consultants in the following headquarter city: Minneapolis
The Senior Hematology Sales Consultant is a key member of the sales organization. This person will be a member of our field organization that will promote IDHIFA® in a co-promotion with Celgene, and Tibsovo®, a wholly owned product, both in hematology.
The Senior Hematology Sales Consultant will work closely with commercial leadership, marketing, marketing analytics, market access, patient advocacy, and medical affairs to ensure alignment and to meet corporate objectives. Specific responsibilities include:
Qualifications, Education and Experience
Current travel requirements are limited due to COVID. Both virtual or in-person meetings are encouraged as needed and appropriate. As things open back-up and travel restrictions are lifted, territory requirement will be an average of 25% based on a Minneapolis location as the primary residence. Occasional weekend travel based on needs within the territory.
Valid through: 3/16/2021
$100K — $150K
16 days ago